Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples